US 12,329,930 B2
Subarachnoid fluid management method and system
Gianna N. Riccardi, South Berwick, ME (US); William X. Siopes, Jr., Lowell, MA (US); Marcie Glicksman, Salem, MA (US); Anthony DePasqua, Newburyport, MA (US); Kevin Kalish, Newburyport, MA (US); Joshua G. Vose, Seattle, WA (US); and Rajan Patel, Somerville, MA (US)
Assigned to EnClear Therapies, Inc., Newburyport, MA (US)
Filed by EnClear Therapies, Inc., Newburyport, MA (US)
Filed on Sep. 29, 2021, as Appl. No. 17/489,625.
Claims priority of provisional application 63/117,975, filed on Nov. 24, 2020.
Claims priority of provisional application 63/084,996, filed on Sep. 29, 2020.
Prior Publication US 2022/0096744 A1, Mar. 31, 2022
Int. Cl. A61M 5/168 (2006.01); A61M 5/145 (2006.01); A61M 5/142 (2006.01)
CPC A61M 5/16827 (2013.01) [A61M 5/145 (2013.01); A61M 5/16886 (2013.01); A61M 2005/14208 (2013.01); A61M 2202/0464 (2013.01); A61M 2205/3344 (2013.01); A61M 2205/3389 (2013.01); A61M 2210/0693 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A CSF management system for use with a patient having a body with CSF having a natural flow rate, the system comprising:
a CSF circuit configured to control flow of the CSF in the body;
a therapeutic input fluidly coupled with the CSF circuit and configured to receive a bolus of therapeutic material into the CSF circuit;
a pump configured to direct the therapeutic material, via the CSF circuit, toward a prescribed portion of the body; and
a controller configured to vary the flow of the CSF in the CSF circuit to localize the CSF at the prescribed portion of the body, wherein varying comprises oscillating a direction of the CSF flow between opposing directions within the CSF circuit to maintain therapeutic material in the prescribed portion of the body.